Literature DB >> 31060978

Guadecitabine in myelodysplastic syndromes: promising but there is still progress to be made.

Lionel Adès1, Marie Sebert2, Pierre Fenaux2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31060978     DOI： 10.1016/S2352-3026(19)30079-1

Source DB:  PubMed          Journal:  Lancet Haematol        ISSN： 2352-3026            Impact factor:   18.959


× No keyword cloud information.
  1 in total

1.  Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia.

Authors:  Hetty E Carraway; Sridhar A Malkaram; Yana Cen; Aymen Shatnawi; Jun Fan; Hamdy E A Ali; Zakaria Y Abd Elmageed; Thomm Buttolph; James Denvir; Donald A Primerano; Tamer E Fandy
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.